logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
05/12/2025
Yuekang Pharmaceutical: plans to issue H shares and list on the Hong Kong Stock Exchange.
Latest
2 m ago
Shanghai Stock Exchange requires securities firms to conduct self-inspections in 2025, with a focus on the new Sci-Tech Innovation Board Growth Enterprise Market.
2 m ago
Liao Min meets with the Director of the French Ministry of Economy and Finance's Fiscal Policy Office, Dumont.
2 m ago
Lianlong: Intends to purchase 30% equity of Lianlong Kerun for 78 million yuan, and intends to purchase 31.2644% equity of Lianlong Chifeng for 68.7815 million yuan.
2 m ago
Jiangnan Yifan: Shareholder Liu Jincheng plans to reduce his stake by 2.51%.
3 m ago
Lishangguochao (600738.SH) received the administrative supervision decision letter from the Gansu Securities Regulatory Bureau.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.